Efficacy and Toxicity of Postoperative Temozolomide Radiochemotherapy in Malignant Glioma

Recursive Partitioning Analysis of Prognostic Factors in Three Radiation Therapy Oncology Group Malignant Glioma Trials

W.J. Curran, Charles Scott, John Horton et al. · JNCI Journal of the National Cancer Institute · 1993 · 1.3K citations

Medicine, Oncology, Radiation Oncology +10

Promising Survival for Patients With Newly Diagnosed Glioblastoma Multiforme Treated With Concomitant Radiation Plus Temozolomide Followed by Adjuvant Temozolomide

Roger Stupp, Pierre-Yves Dietrich, Sandrine Ostermann Kraljevic et al. · Journal of Clinical Oncology · 2002 · 815 citations

Medicine, Oncology, Radiation Oncology +17

Chemotherapy for anaplastic oligodendroglioma. National Cancer Institute of Canada Clinical Trials Group.

Gregory Cairncross, David Macdonald, Samuel K. Ludwin et al. · Journal of Clinical Oncology · 1994 · 443 citations

Medicine, Oncology, Radiation Oncology +17

Molecular subtypes of anaplastic oligodendroglioma: implications for patient management at diagnosis.

Yasushi Ino, Rebecca A. Betensky, Magdalena C. Ƶlatescu et al. · PubMed · 2001 · 435 citations

Medicine, Molecular Genetics, Oncology +17

Phase II Study of First-Line Chemotherapy With Temozolomide in Recurrent Oligodendroglial Tumors: The European Organization for Research and Treatment of Cancer Brain Tumor Group Study 26971

Martin J. van den Bent, Alba A. Brandes, Johan Menten et al. · Journal of Clinical Oncology · 2003 · 296 citations

Medicine, Oncology, Surgery +17